Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties
Open Access
- 17 November 2017
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20160618
Abstract
The pathophysiology of obstructive pulmonary diseases, such as cystic fibrosis (CF), leads to the development of chronic infections in the respiratory tract. Thus, the symptomatic management of the disease requires, in particular, repetitive antibiotherapy. Besides these antibacterial treatments, certain pathologies, such as CF or chronic obstructive pulmonary disease (COPD), require the intake of many drugs. This simultaneous absorption may lead to undesirable drug interactions. For example, Orkambi® (lumacaftor/Ivacaftor, Vertex), a pharmacological drug employed to treat F508del patients, cannot be used with antibiotics such as rifampicin or rifabutin (rifamycin family) which are necessary to treat Mycobacteriaceae. As far as gene therapy is concerned, bacteria and/or biofilm in the airways present an additional barrier for gene transfer. Thus, aerosol administration of nanoparticles have to overcome many obstacles before allowing cellular penetration of therapeutic compounds. This review focusses on the development of aerosol formulations adapted to the respiratory tract and its multiple barriers. Then, formulations that are currently used in clinical applications are summarized depending on the active molecule delivered. Finally, we focus on new therapeutic approaches to reduce possible drug interactions by transferring the antibacterial activity to the nanocarrier while ensuring the transfection efficiency.Keywords
This publication has 124 references indexed in Scilit:
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfectionThorax, 2013
- Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhiChemistry Central Journal, 2013
- Supercoiled Minivector DNA resists shear forces associated with gene therapy deliveryGene Therapy, 2011
- Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis PatientsPLOS ONE, 2011
- Novel Cationic Lipids with Enhanced Gene Delivery and Antimicrobial ActivityMolecular Pharmacology, 2010
- Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic FibrosisPLOS ONE, 2009
- A series of cationic sterol lipids with gene transfer and bactericidal activityBioorganic & Medicinal Chemistry, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Micro- and macrorheology of mucusAdvanced Drug Delivery Reviews, 2009
- Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interferenceProceedings of the National Academy of Sciences of the United States of America, 2007